CO5670349A2 - Jarabe multivitaminico para niños o adultos jovenes - Google Patents
Jarabe multivitaminico para niños o adultos jovenesInfo
- Publication number
- CO5670349A2 CO5670349A2 CO06015590A CO06015590A CO5670349A2 CO 5670349 A2 CO5670349 A2 CO 5670349A2 CO 06015590 A CO06015590 A CO 06015590A CO 06015590 A CO06015590 A CO 06015590A CO 5670349 A2 CO5670349 A2 CO 5670349A2
- Authority
- CO
- Colombia
- Prior art keywords
- vitamin
- composition according
- calcium
- acid
- arginine
- Prior art date
Links
- 239000006188 syrup Substances 0.000 title abstract 2
- 235000020357 syrup Nutrition 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 4
- 239000004475 Arginine Substances 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 2
- 229930003451 Vitamin B1 Natural products 0.000 abstract 2
- 229930003471 Vitamin B2 Natural products 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 229930003427 Vitamin E Natural products 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 235000006708 antioxidants Nutrition 0.000 abstract 2
- 229960005069 calcium Drugs 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 abstract 2
- 239000001527 calcium lactate Substances 0.000 abstract 2
- 229960002401 calcium lactate Drugs 0.000 abstract 2
- 235000011086 calcium lactate Nutrition 0.000 abstract 2
- 239000000686 essence Substances 0.000 abstract 2
- 239000000796 flavoring agent Substances 0.000 abstract 2
- 235000013355 food flavoring agent Nutrition 0.000 abstract 2
- 235000019264 food flavour enhancer Nutrition 0.000 abstract 2
- 235000003599 food sweetener Nutrition 0.000 abstract 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
- 229960003966 nicotinamide Drugs 0.000 abstract 2
- 235000005152 nicotinamide Nutrition 0.000 abstract 2
- 239000011570 nicotinamide Substances 0.000 abstract 2
- 229950008882 polysorbate Drugs 0.000 abstract 2
- 229920000136 polysorbate Polymers 0.000 abstract 2
- 235000010241 potassium sorbate Nutrition 0.000 abstract 2
- 239000004302 potassium sorbate Substances 0.000 abstract 2
- 229940069338 potassium sorbate Drugs 0.000 abstract 2
- 239000003755 preservative agent Substances 0.000 abstract 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 2
- 229960002477 riboflavin Drugs 0.000 abstract 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 abstract 2
- 239000000600 sorbitol Substances 0.000 abstract 2
- 239000003765 sweetening agent Substances 0.000 abstract 2
- 229960003080 taurine Drugs 0.000 abstract 2
- 229960003495 thiamine Drugs 0.000 abstract 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 2
- 229940088594 vitamin Drugs 0.000 abstract 2
- 229930003231 vitamin Natural products 0.000 abstract 2
- 235000013343 vitamin Nutrition 0.000 abstract 2
- 239000011782 vitamin Substances 0.000 abstract 2
- 235000010374 vitamin B1 Nutrition 0.000 abstract 2
- 239000011691 vitamin B1 Substances 0.000 abstract 2
- 235000019164 vitamin B2 Nutrition 0.000 abstract 2
- 239000011716 vitamin B2 Substances 0.000 abstract 2
- 235000019158 vitamin B6 Nutrition 0.000 abstract 2
- 239000011726 vitamin B6 Substances 0.000 abstract 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 2
- 235000005282 vitamin D3 Nutrition 0.000 abstract 2
- 239000011647 vitamin D3 Substances 0.000 abstract 2
- 235000019165 vitamin E Nutrition 0.000 abstract 2
- 239000011709 vitamin E Substances 0.000 abstract 2
- 229940046009 vitamin E Drugs 0.000 abstract 2
- 229940011671 vitamin b6 Drugs 0.000 abstract 2
- 229940021056 vitamin d3 Drugs 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 abstract 1
- 235000004866 D-panthenol Nutrition 0.000 abstract 1
- 239000011703 D-panthenol Substances 0.000 abstract 1
- 239000004097 EU approved flavor enhancer Substances 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 229960003949 dexpanthenol Drugs 0.000 abstract 1
- 235000007882 dietary composition Nutrition 0.000 abstract 1
- 235000011007 phosphoric acid Nutrition 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 abstract 1
- 235000010234 sodium benzoate Nutrition 0.000 abstract 1
- 239000004299 sodium benzoate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
1.- Una composición farmacéutica o dietética en forma de un jarabe acuoso, que consta esencialmente de (a) las vitaminas recomendadas para el consumo de niños o adultos jóvenes, (b) una fuente de calcio, (c) al menos un aminoácido dibásico, (d) taurina, (e) al menos un solubilizante, (f) al menos un agente adicional seleccionado del grupo constituido por agentes edulcorantes, agentes aromatizantes, mejoradores del sabor, conservantes, antioxidantes, co-disolventes, y (g) agua, cuya mejora consiste en que los aminoácidos (c) comprenden arginina y lisina.2.- Una composición según la reivindicación 1, en la que las (f) vitaminas (a) se seleccionan del grupo constituido por Vitamina B1, Vitamina B2, Vitamina B6, Vitamina D3, Vitamina E, Dexpantenol y Nicotinamida.3.- Una composición según las reivindicaciones 1 o 2, en la que la fuente de calcio (b) se selecciona entre lactato de calcio y carbonato de calcio.4.- Una composición según una cualquiera de las reivindicaciones precedentes, en la que el aminoácido dibásico (c) es arginina y/o lisina.5.- Una composición según una cualquiera de las reivindicaciones precedentes, en la que el solubilizante (e) es al menos un polisorbato.6.- Una composición según una cualquiera de las reivindicaciones precedentes, en la que el agente adicional (f) comprende al menos un agente edulcorante, al menos un agente aromatizante, al menos un mejorador del sabor, al menos un conservante, al menos un antioxidante, y al menos un co-disolvente.7.- Una composición según una cualquiera de las reivindicaciones precedentes, en la que el agente adicional (f) consta esencialmente de sorbitol, sacarina sódica, esencia de naranja, ácido fosfórico, ácido cítrico, sorbato de potasio, benzoato de sodio, edetato de disodio, ácido (L)-ascórbico y etanol.8.- Una composición según una cualquiera de las reivindicaciones precedentes, que consta esencialmente de(a) Vitamina B1, Vitamina B2, Vitamina B6, Vitamina D3, Vitamina E, Dexpantenol y Nicotinamida;(b) lactato de calcio;(c) arginina e hidrocloruro de (L)-lisina; (d) taurina;(e) al menos un polisorbato; sorbitol, sacarina sódica, esencia de naranja, ácido fosfórico, ácido cítrico, sorbato de potasio, benzoato de sodio, edetato de disodio, ácido (L)-ascórbico y etanol; y (g) agua.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03018606 | 2003-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5670349A2 true CO5670349A2 (es) | 2006-08-31 |
Family
ID=34178386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO06015590A CO5670349A2 (es) | 2003-08-19 | 2006-02-16 | Jarabe multivitaminico para niños o adultos jovenes |
Country Status (28)
Country | Link |
---|---|
US (1) | US7691871B2 (es) |
EP (1) | EP1658079B1 (es) |
JP (1) | JP5009616B2 (es) |
KR (1) | KR20060066732A (es) |
CN (1) | CN1835752B (es) |
AR (1) | AR045460A1 (es) |
AT (1) | ATE554771T1 (es) |
AU (1) | AU2004264675B2 (es) |
BR (1) | BRPI0413618B8 (es) |
CA (1) | CA2536135C (es) |
CO (1) | CO5670349A2 (es) |
CY (1) | CY1113133T1 (es) |
DK (1) | DK1658079T3 (es) |
EC (1) | ECSP066385A (es) |
ES (1) | ES2386635T3 (es) |
HK (1) | HK1093306A1 (es) |
IL (1) | IL173774A0 (es) |
MX (1) | MXPA06001706A (es) |
MY (1) | MY142802A (es) |
PE (1) | PE20050368A1 (es) |
PL (1) | PL1658079T3 (es) |
PT (1) | PT1658079E (es) |
RU (1) | RU2369271C2 (es) |
SI (1) | SI1658079T1 (es) |
TW (1) | TW200517140A (es) |
UA (1) | UA83063C2 (es) |
WO (1) | WO2005016345A1 (es) |
ZA (1) | ZA200600203B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004041270A1 (de) * | 2004-08-26 | 2006-03-02 | Merz Pharma Gmbh & Co. Kgaa | Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
AR070357A1 (es) * | 2008-02-08 | 2010-03-31 | Colgate Palmolive Co | Producto para cuidado oral y metodos de uso y manufactura del mismo |
ES2522629T3 (es) | 2009-01-08 | 2014-11-17 | Merck Patent Gmbh | Nuevas formas polimórficas de la sal clorhidrato de 3-(1-{3-[5-(1-metil-piperidin-4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3-il)-benzonitrilo y procesos de producción de las mismas |
US8962042B2 (en) * | 2010-09-28 | 2015-02-24 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
US9931365B2 (en) | 2010-09-28 | 2018-04-03 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
CN105166935B (zh) * | 2015-09-01 | 2018-08-31 | 张伟 | 一种含有维生素d3的液体制剂及其制备方法 |
CN109845936A (zh) * | 2019-01-21 | 2019-06-07 | 刘宪忠 | 一种多口味饮用水及其制备方法 |
CN112336731B (zh) * | 2020-11-02 | 2021-12-14 | 北京诺康达医药科技股份有限公司 | 一种维生素口服液及其制备方法与应用 |
CA3229336A1 (en) * | 2021-08-17 | 2023-02-23 | Michael Walters | Multivitamin for cystic fibrosis patients undergoing cystic fibrosis transmembrane conductance regulator gene modulator therapy |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3099722A (en) * | 1959-12-28 | 1963-07-30 | Gracia Luis Vila | Floating suspension including switching means for friction rollers |
RO76070A2 (ro) * | 1978-12-01 | 1983-06-01 | Intreprinderea De Medicamente "Biofarm",Ro | Sirop polivitaminat pentru us infantil |
EP0093090B1 (en) | 1982-04-23 | 1987-01-21 | CAPSULIT S.r.l. | A closure for bottles and the like of the type including a breakable bottom reservoir to break during use |
IT1217761B (it) | 1988-06-01 | 1990-03-30 | Dam Technological Research Ltd | Tappo serbatoio per polveri |
US4992282A (en) * | 1989-05-08 | 1991-02-12 | The Procter & Gamble Company | Stable nutritional vitamin and mineral supplemented beverage |
IL101007A (en) * | 1992-02-18 | 1997-08-14 | Pharmos Ltd | Dry stable compositions prepared by lyophilization |
EP0577200B1 (en) | 1992-07-02 | 1996-07-03 | Laboratorios Cusi, S.A. | Pharmaceutical product container for two separate substances, having a device for mixing and dosed dispensation |
IT227015Y1 (it) | 1992-11-27 | 1997-09-09 | Ibsa Inst Biochimique Sa | Dispositivo dosatore per sciroppi estemporanei multidose ad uso farmaceutico |
US5965162A (en) * | 1993-09-10 | 1999-10-12 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
US5770215A (en) * | 1997-01-06 | 1998-06-23 | Moshyedi; Emil Payman | Multivitamin/vascular occlusion inhibiting composition |
US5922766A (en) * | 1997-07-02 | 1999-07-13 | Acosta; Phyllis J. B. | Palatable elemental medical food |
US6475539B1 (en) * | 1998-05-07 | 2002-11-05 | Abbott Laboratories | Nutritionally complete low pH enteral formula |
DE20116346U1 (de) * | 2001-10-05 | 2001-12-20 | Orthomol Pharmazeutische Vertr | Mikronährstoffkombinationsprodukt u.a. mit Vitaminen und Carotinoiden |
US20030099722A1 (en) * | 2001-10-09 | 2003-05-29 | Baxter Jeffrey H. | Methods and compositions for providing glutamine |
UY27505A1 (es) * | 2001-10-23 | 2003-06-30 | Boehringer Ingelheim Int | Tableta masticable que contiene lisina |
DE10245172A1 (de) | 2002-09-26 | 2004-04-01 | Boehringer Ingelheim International Gmbh | Zweikomponenten-Verpackungseinheit |
-
2004
- 2004-08-13 MX MXPA06001706A patent/MXPA06001706A/es active IP Right Grant
- 2004-08-13 AU AU2004264675A patent/AU2004264675B2/en not_active Ceased
- 2004-08-13 PT PT04764115T patent/PT1658079E/pt unknown
- 2004-08-13 RU RU2006108468/15A patent/RU2369271C2/ru active
- 2004-08-13 KR KR1020067003287A patent/KR20060066732A/ko not_active Application Discontinuation
- 2004-08-13 BR BRPI0413618A patent/BRPI0413618B8/pt not_active IP Right Cessation
- 2004-08-13 DK DK04764115.4T patent/DK1658079T3/da active
- 2004-08-13 WO PCT/EP2004/009121 patent/WO2005016345A1/en active Application Filing
- 2004-08-13 EP EP04764115A patent/EP1658079B1/en active Active
- 2004-08-13 SI SI200431890T patent/SI1658079T1/sl unknown
- 2004-08-13 ES ES04764115T patent/ES2386635T3/es active Active
- 2004-08-13 CN CN2004800236292A patent/CN1835752B/zh not_active Expired - Fee Related
- 2004-08-13 UA UAA200602903A patent/UA83063C2/ru unknown
- 2004-08-13 PL PL04764115T patent/PL1658079T3/pl unknown
- 2004-08-13 CA CA2536135A patent/CA2536135C/en not_active Expired - Fee Related
- 2004-08-13 AT AT04764115T patent/ATE554771T1/de active
- 2004-08-13 JP JP2006523587A patent/JP5009616B2/ja not_active Expired - Fee Related
- 2004-08-16 US US10/918,990 patent/US7691871B2/en not_active Expired - Fee Related
- 2004-08-17 MY MYPI20043340A patent/MY142802A/en unknown
- 2004-08-17 PE PE2004000792A patent/PE20050368A1/es not_active Application Discontinuation
- 2004-08-18 TW TW093125037A patent/TW200517140A/zh unknown
- 2004-08-18 AR ARP040102954A patent/AR045460A1/es not_active Application Discontinuation
-
2006
- 2006-01-09 ZA ZA200600203A patent/ZA200600203B/en unknown
- 2006-02-16 CO CO06015590A patent/CO5670349A2/es not_active Application Discontinuation
- 2006-02-16 IL IL173774A patent/IL173774A0/en unknown
- 2006-02-17 EC EC2006006385A patent/ECSP066385A/es unknown
- 2006-12-21 HK HK06114061.9A patent/HK1093306A1/xx not_active IP Right Cessation
-
2012
- 2012-07-20 CY CY20121100649T patent/CY1113133T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5670349A2 (es) | Jarabe multivitaminico para niños o adultos jovenes | |
CY1120513T1 (el) | Υψηλης συμπυκνωσης συνθεση μινοξιδιλης | |
TW200621271A (en) | Aspartame and citrate flavored phosphate salt laxative | |
PE20060935A1 (es) | Composicion farmaceutica que comprende diclofenaco | |
AR073793A1 (es) | Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido | |
AR052252A1 (es) | Formulaciones topicas de nepafenac | |
US10617700B1 (en) | Vitamin supplement compositions with enhanced bioavailability | |
PT96506A (pt) | Processo para a preparacao de composicoes orais que incorporam como ingrediente activo pimobendano | |
AR070593A1 (es) | Composiciones efervescentes | |
JPH07227256A (ja) | 経口液剤 | |
AR068327A1 (es) | Composicion farmaceutica liquida estable a base de trazodona | |
PE20030545A1 (es) | Formulaciones de jarabe de ribavirina | |
JP2004261181A (ja) | 唾液のための調製物 | |
BR0013651A (pt) | Tratamento de enxaqueca pela administração de ácido alfalipóico ou seus derivados | |
ATE242626T1 (de) | Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält | |
KR950010880A (ko) | 안정한 복합비타민 내복액제 | |
AR030715A1 (es) | Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones | |
AR053333A1 (es) | Composiciones farmaceuticas orales y parenterales que contienen altas concentraciones de agentes solubilizantes aromaticos | |
US20060024351A1 (en) | Hydrating breath freshening beverage compositions and method therefor | |
ITRM20030485A1 (it) | Composizione a base di citicolina in associazione con vitamine per la prevenzione ed il trattamento di patolgie oculari. | |
AR041331A1 (es) | Composiciones detergentes que comprenden granulos efervescentes | |
JP2017095372A (ja) | ビオチン含有液剤 | |
RU2020123018A (ru) | Пищевая добавка, ее применение, способ дополнительного питания и пероральный спрей | |
WO2012120536A3 (en) | An energy drink suitable for humane consumption | |
RU2004134274A (ru) | Комбинированный поливитаминный состав и способ его получения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |